People · Operator
Named in public records as an officer, director or promoter · active 2014–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Araim Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $8.1M | $127.1M | 2014 |
Michael Brines at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Brines on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gerald Bernstein | 1 | 2 |
| John Macomber | 1 | 2 |
| Sarah Haley | 1 | 1 |
| Anthony Cerami | 1 | 1 |
| Rita Kirk | 1 | 1 |
| Ann Dunne | 1 | 1 |
| Sidney Strickland | 1 | 1 |
| Ferry Breedveld | 1 | 1 |
| Scott Grundy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.